Product Information

CLONAZEPAM 1 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0242 per EA under NDC 72888015305. Its NADAC has been published 182 times since May 31, 2023.

FDA first approved this application on Oct 6, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLONAZEPAM 1 MG TABLET

Clonazepam
$0.0242per EA
DEA Schedule CIV

Strength

1 mg/1

NDC

72888015305

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CLONAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA075468

FDA Approved

10/6/2000

TE Code

AB

On Market Since

4/14/2022

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for CLONAZEPAM 1 MG TABLET has been published 182 times since May 31, 2023, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0242 per EA
All-time high$0.0342 (Sep 13, 2023)
All-time low$0.0242 (Nov 18, 2026)
52-week high$0.0282
52-week low$0.0242
Median price$0.0292
Average price$0.0287
Largest weekly change+23.6% (Jun 19, 2024)
Weeks tracked182
Tracking sinceMay 31, 2023

Price History

1W

-1.3%

1M

-0.7%

3M

-1.3%

6M

-3.2%

1Y

-14.2%

3Y

-23.8%

5Y

N/A

All

-26.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLONAZEPAM 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0242 per EA (NDC 72888015305), effective Nov 18, 2026.

How has the price of CLONAZEPAM 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLONAZEPAM 1 MG TABLET has declined 26.5%. It has been tracked across 182 weekly CMS publications since May 31, 2023.

What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG TABLET?

Since May 31, 2023, the NADAC for CLONAZEPAM 1 MG TABLET has ranged from a low of $0.0242 (Nov 18, 2026) to a high of $0.0342 (Sep 13, 2023), with a median of $0.0292 per EA.

Are there cheaper alternatives to CLONAZEPAM 1 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 1 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLONAZEPAM 1 MG TABLET?

CLONAZEPAM 1 MG TABLET (NDC 72888015305) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.